Reported Standalone quarterly numbers for Krebs Biochemicals & Industries are:
Net Sales at Rs 11.47 crore in December 2024 down 11.64% from Rs. 12.98 crore in December 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 7.74 crore in December 2024 down 55.48% from Rs. 4.98 crore in December 2023.
EBITDA stands negative at Rs. 4.46 crore in December 2024 down 116.5% from Rs. 2.06 crore in December 2023.
Krebs Biochem shares closed at 102.95 on February 03, 2025 (NSE) and has given 19.09% returns over the last 6 months and 37.18% over the last 12 months.
Story continues below Advertisement
| Krebs Biochemicals & Industries | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'24 | Sep'24 | Dec'23 | | Net Sales/Income from operations | 11.47 | 12.86 | 12.98 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 11.47 | 12.86 | 12.98 | | EXPENDITURE | | Consumption of Raw Materials | 1.19 | 1.03 | 1.03 | | Purchase of Traded Goods | 0.00 | -- | -- | | Increase/Decrease in Stocks | 0.12 | 1.39 | 0.25 | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.50 | 4.39 | 4.44 | | Depreciation | 1.72 | 1.71 | 1.73 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 10.37 | 8.75 | 9.35 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -6.43 | -4.42 | -3.82 | | Other Income | 0.25 | 0.09 | 0.03 | | P/L Before Int., Excpt. Items & Tax | -6.18 | -4.34 | -3.79 | | Interest | 1.56 | 1.42 | 1.19 | | P/L Before Exceptional Items & Tax | -7.74 | -5.76 | -4.98 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -7.74 | -5.76 | -4.98 | | Tax | -- | -- | -- | | P/L After Tax from Ordinary Activities | -7.74 | -5.76 | -4.98 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -7.74 | -5.76 | -4.98 | | Equity Share Capital | 21.56 | 21.56 | 21.56 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.59 | -2.67 | -2.31 | | Diluted EPS | -3.59 | -2.67 | -2.31 | | EPS After Extra Ordinary | | Basic EPS | -3.59 | -2.67 | -2.31 | | Diluted EPS | -3.59 | -2.67 | -2.31 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
